Diabetes and the nervous system (Q41107228)

26 September 2017

1 reference

title

Diabetes and the nervous system (English)

1 reference

26 September 2017

Harati Y

1

1 reference

26 September 2017

1 June 1996

1 reference

Endocrinology and Metabolism Clinics of North America

26 September 2017

1 reference

26 September 2017

25

1 reference

26 September 2017

2

1 reference

26 September 2017

325-359

1 reference

Denervation and hyperinnervation in the nervous system of diabetic animals: III. Functional alterations of G proteins in diabetic encephalopathy

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The natural history of acute painful neuropathy in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Multiple cerebral haematomata and peripheral nerve palsies associated with a case of juvenile diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Spontaneous intracerebral hematomas in juvenile diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Biological differences between ischemia, hypoglycemia, and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The distribution of hypoglycemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Progress review: hypoglycemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Stroke in the diabetic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The association of hyperglycemia with cerebral edema in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

1 reference

7 January 2021

End-stage complications of diabetic neuropathy: foot ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic neuropathy, nerve growth factor and other neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

50% dextrose: antidote or toxin?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Glycation products and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The prognostic value of blood glucose and glycosylated haemoglobin estimation in patients with stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Neurotrophic factors in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Neurotrophic factors in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Ganglioside treatment in diabetic peripheral neuropathy: A multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hyperosmolar coma: cellular dehydration and the serum sodium concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The role of autonomic neuropathy in diabetic foot ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Evidence for Diabetic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Mexiletine for treatment of chronic painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Regional cerebral blood flow decreases during chronic and acute hyperglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Regional cerebral glucose utilization during hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Glucose transfer into rat brain during acute and chronic hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Asymmetric proliferative diabetic retinopathy and carotid artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Capillary number and percentage closed in human diabetic sural nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic neuropathic cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Low serum levels of nerve growth factor in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Cognitive processes in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Nerve Growth Factor and Insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Selective vulnerability of cultured cortical glia to injury by extracellular acidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Rodent models of cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Blood-brain glucose transfer: repression in chronic hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Increasing age, diabetes mellitus and recovery from stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Complications: neuropathy, pathogenetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Abnormal cerebrovascular carbon dioxide reactivity in people with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Neurologic manifestations of diabetic comas: correlation with biochemical alterations in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Trial of ganglioside therapy for diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Insulin reduction of cerebral infarction due to transient focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Renal cellular biology of growth hormone and insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic peripheral neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Cerebral extracellular calcium activity in severe hypoglycemia: relation to extracellular potassium and energy state.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Blood glucose and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The role of neuronal energy in the neurotoxicity of excitatory amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Verbal fluency and naming performance in type I diabetes at different blood glucose concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic 3rd nerve palsy: evidence for a mesencephalic lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Apolipoprotein E metabolism in sciatic nerves of diabetic rats. Implication for diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Impaired autoregulation of cerebral blood flow in long-term type I (insulin-dependent) diabetic patients with nephropathy and retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Autonomic neuropathy and corrected QT interval prolongation. There is a relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effects of Pancreatic Transplantation on Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effects of insulin and hypoglycemia on the auditory brain stem response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Reduced aminergic synthesis in the hypothalamus of the infertile, genetically diabetic (C57BL/KsJ-db/db) male mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Non-NMDA receptor-mediated neurotoxicity in cortical culture

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Subclinical brain swelling in children during treatment of diabetic ketoacidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effect of long-lasting diabetes mellitus on rat and human brain monoamines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Regional comparisons of brain glucose influx.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Oxygen free radical effects in sciatic nerve in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Recent advances in the pathogenesis of diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Transperineurial Capillary Abnormalities in the Sural Nerve of Patients with Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Mendenhall's syndrome: clues to the aetiology of human diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hypoxic neuropathy: relevance to human diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hypoglycemia: causes, neurological manifestations, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Cerebral oedema complicating diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Brain uptake of glucose in diabetes mellitus: the role of glucose transporters.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic complications of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Possible association between tardive dyskinesia and altered carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Severe autonomic neuropathy: how many symptoms?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Brain Metabolism during Fasting*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetes as risk factor for transient ischaemic attacks as opposed to strokes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Regulation of extra- and intracellular pH in the brain in severe hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Retinopathy as a risk factor for nonembolic stroke in diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Increased frequency of diabetes mellitus in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Postural hypotension in diabetic autonomic neuropathy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Calcitonin in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Acetyl-L-carnitine for symptomatic diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Vascular Insufficiency Quantitatively Aggravates Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Relationship between hyperglycemia and cognitive function in older NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Brain Lactic Acidosis and Ischemic Cell Damage: 1. Biochemistry and Neurophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Intensified conventional insulin treatment and neuropsychological impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Sudden cardiorespiratory arrest after renal transplantation in a patient with diabetic autonomic neuropathy and prolonged QT interval.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and transient ischemic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Regional cerebral blood flow and cerebrovascular reactivity in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Intracerebral crises during treatment of diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetes as an atherogenic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Non-enzymatic glycation of peripheral nerve proteins in human diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Nerve biopsy findings in different patterns of proximal diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Glucose potentiates haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Risk factors for neuroleptic-induced movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The relationship between diabetes mellitus and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effect of insulin on central catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

1 reference

7 January 2021

Post-ischemic coma in rat: effect of different pre-ischemic blood glucose levels on cerebral metabolic recovery after ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic neuropathy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Peripheral neuropathy after chronic endoneurial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The sorbinil retinopathy trial: neuropathy results. Sorbinil Retinopathy Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic truncal neuropathy: topography of the sensory deficit

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Insulin and atheroma. 20-yr perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Mexiletine in the treatment of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

1 reference

7 January 2021

Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

New clinical experience with tramadol.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Thioctic Acid and Dihydrolipoic Acid are Novel Antioxidants Which Interact With Reactive Oxygen Species

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Anticonvulsant drugs and chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Clonidine and diabetic patients with leg pains

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Cerebral edema, diabetes insipidus, and sudden death during the treatment of diabetic ketoacidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Vascular factors in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Growth factors and diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Polyols and myo-inositol in diabetic neuropathy--of mice and men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Memory self-assessment and performance in aged diabetics and non-diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Autonomic neuropathy and transcutaneous oxymetry in diabetic lower extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Possible mechanism for cerebral oedema in diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hyperglycemia preserves brain mitochondrial respiration during anoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Natural history of the diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Moderate hypoglycemia impairs the function of the inferior colliculus in the awake rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Treatment of hyperesthetic neuropathic pain in diabetics. Decompression of the tarsal tunnel

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Endoneurial blood flow changes in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Brain catechol synthesis: control by train tyrosine concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Hyperglycemia decreases acute neuronal ischemic changes after middle cerebral artery occlusion in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

Neuropsychological profiles in men with insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970327-3

7 January 2021

10.1016/S0889-8529(05)70327-3

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8799703